Appears On
Episode Appearances
Biotech Hangout · May 8, 2026
Episode 182 - May 8, 2026
“Analyst covering commercial-stage biotech and earnings; discussed investor rotation away from commercial names”
Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns
View Analysis